Chameleon Biosciences
Chameleon Biosciences is transforming gene therapy with a re-dosable, AAV based gene therapy.
Based based in San Francisco Bay Area, West Coast, Western US, Chameleon Biosciences works in biotechnology, genetics, therapeutics, founded in 2017.
Within the biotechnology, genetics, therapeutics space, the company focuses on its core offering rather than a broad product line.
The company is recorded as being based in San Francisco Bay Area, West Coast, Western US.
It is recorded at the Seed stage.
Recorded headcount: c_00001_00010 employees.
It has disclosed roughly $14.2M in funding.
| Sector | Biotechnology, Genetics, Therapeutics |
|---|---|
| Headquarters | San Francisco Bay Area, West Coast, Western US |
| Country | United States |
| Founded | 2017 |
| Employees | c_00001_00010 |
| Stage | seed |
| Total funding | $14,200,000 |
Website: chameleonbiosci.com
Browse related
Sign in to view the contact information we hold for Chameleon Biosciences.
Create a free account
Create a free account